SRPT Articles, Sarepta Therapeutics Inc. - From 06/26/24

Roche (OTC: RHHBY) announced that the European Commission has granted marketing authorization to the subcutaneous formulation of relapsing mul...

Sarepta Therapeutics (NASDAQ:SRPT) has outperformed the market over the past 10 years by 7.68% on an annualized basis producing an average annual r...

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgr...

These large-cap stocks were the best performers in the last week. Are they in your portfolio? Sarepta Therapeutics, Inc. (NASDAQ:SRPT) shares incr...

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite moving lower on Friday. The Dow traded down 0.01% to 39,133.99 while ...

Shares of Kaival Brands Innovations Group, Inc. (NASDAQ:KAVL) fell sharply during Friday's session after the company announced pricing of $6.0...

Shares of Catalent Inc (NYSE:CTLT), which manufactures Elevidys, are trading higher with a strong session volume of 3.6 million compared to an aver...

On Thursday, the FDA approved the labeled indication for Sarepta Therapeutics Inc’s (NASDAQ:SRPT) Elevidys (delandistrogene moxeparvovec...

U.S. stocks traded mixed midway through trading, with the Dow Jones index edging higher on Friday. The Dow traded up 0.02% to 39,142.01 while the N...

U.S. stocks were mixed, with the Dow Jones index gaining around 50 points on Friday. Shares of Asana, Inc. (NYSE:ASAN) rose sharply during Friday&#...